1. Home
  2. BNED vs ALLO Comparison

BNED vs ALLO Comparison

Compare BNED & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNED
  • ALLO
  • Stock Information
  • Founded
  • BNED 1965
  • ALLO 2017
  • Country
  • BNED United States
  • ALLO United States
  • Employees
  • BNED N/A
  • ALLO N/A
  • Industry
  • BNED Other Specialty Stores
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BNED Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • BNED Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • BNED 371.2M
  • ALLO 371.8M
  • IPO Year
  • BNED N/A
  • ALLO 2018
  • Fundamental
  • Price
  • BNED $12.03
  • ALLO $1.17
  • Analyst Decision
  • BNED Hold
  • ALLO Strong Buy
  • Analyst Count
  • BNED 1
  • ALLO 9
  • Target Price
  • BNED N/A
  • ALLO $8.44
  • AVG Volume (30 Days)
  • BNED 365.7K
  • ALLO 4.1M
  • Earning Date
  • BNED 06-30-2025
  • ALLO 05-13-2025
  • Dividend Yield
  • BNED N/A
  • ALLO N/A
  • EPS Growth
  • BNED N/A
  • ALLO N/A
  • EPS
  • BNED N/A
  • ALLO N/A
  • Revenue
  • BNED $1,567,800,000.00
  • ALLO N/A
  • Revenue This Year
  • BNED $2.74
  • ALLO N/A
  • Revenue Next Year
  • BNED N/A
  • ALLO $10.02
  • P/E Ratio
  • BNED N/A
  • ALLO N/A
  • Revenue Growth
  • BNED N/A
  • ALLO N/A
  • 52 Week Low
  • BNED $6.05
  • ALLO $0.86
  • 52 Week High
  • BNED $81.28
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • BNED 70.50
  • ALLO 44.54
  • Support Level
  • BNED $10.33
  • ALLO $1.02
  • Resistance Level
  • BNED $11.25
  • ALLO $1.15
  • Average True Range (ATR)
  • BNED 0.49
  • ALLO 0.11
  • MACD
  • BNED 0.10
  • ALLO 0.02
  • Stochastic Oscillator
  • BNED 92.90
  • ALLO 75.61

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: